Try our Advanced Search for more refined results
In re: sanofi-aventis Securities Litigation
Case Number:
1:07-cv-10279
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Sectors & Industries:
-
September 19, 2013
Sanofi Settles Obesity Drug Class Action For $40M
French pharmaceutical giant Sanofi-Aventis SA has agreed to pay $40 million to settle a class action brought by investors who claim the company withheld information about anti-obesity drug Zimulti's link to severe psychiatric problems, according to documents filed in New York federal court on Thursday.
-
March 20, 2013
Sanofi Investors Win Class Cert. In Obesity Drug Suit
A New York federal judge on Wednesday certified a class of Sanofi-Aventis SA investors who claim the French pharmaceutical giant withheld information about anti-obesity drug Zimulti's link to severe psychiatric problems, finding the lead plaintiffs' securities fraud claims were typical of the class as a whole.